Literature DB >> 3257364

Attenuation of endothelium-mediated vasodilation by halothane.

S M Muldoon1, J L Hart, K A Bowen, W Freas.   

Abstract

To determine whether halothane alters endothelium-mediated vasodilation of vascular smooth muscle, isolated ring preparations of rabbit aorta and canine femoral and carotid arteries were suspended for isometric tension recordings in Krebs-Ringer bicarbonate solution at 37 degrees C. Acetylcholine and bradykinin have been shown to relax these norepinephrine contracted arteries via an endothelium-dependent process. In this study, these relaxations were reversibly and significantly attenuated by 2% halothane. However, halothane did not affect relaxations caused by nitroglycerin, which, in these vessels, acts by an endothelium independent mechanism. These results suggest that halothane is not interfering with cyclic guanylate-monophosphate mediated relaxation of vascular smooth muscle, but may interfere with the synthesis, release, or transport of the endothelium-derived relaxing factor. In addition, during contractions evoked by norepinephrine, halothane caused significant decreases in tension in both the canine carotid and rabbit aortic preparations, but increased tension in the femoral artery rings. These effects were not altered by mechanical removal of the endothelium. These results suggest a direct action of halothane on the vascular smooth muscle, which can result in either an increase or decrease in tension, depending on the specific vessel. In addition to its direct vascular effect, this study suggests a new action of halothane; it interferes with endothelium-derived relaxing factor-mediated relaxation of vascular smooth muscle. This action may contribute in part to the vascular alterations seen clinically during administration of halothane.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257364     DOI: 10.1097/00000542-198801000-00006

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

1.  Anaphylactic shock depends on PI3K and eNOS-derived NO.

Authors:  Anje Cauwels; Ben Janssen; Emmanuel Buys; Patrick Sips; Peter Brouckaert
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

2.  Volatile anaesthetic actions on norepinephrine-induced contraction of small splanchnic resistance arteries.

Authors:  T Akata; K Kodama; S Takahashi
Journal:  Can J Anaesth       Date:  1995-11       Impact factor: 5.063

3.  Differential vascular reactivity of canine mesenteric arteries and veins to sevoflurane.

Authors:  Kazu-Ichi Yoshida; Akiyoshi Ohsawa
Journal:  J Anesth       Date:  1998-03       Impact factor: 2.078

4.  Halothane inhibits the pressor effect of diphenyleneiodonium.

Authors:  Y X Wang; C C Pang
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

Review 5.  Endothelial vasomotor regulation in health and disease.

Authors:  N R Searle; P Sahab
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

6.  Cerebrovascular responses to carbon dioxide in children anaesthetized with halothane and isoflurane.

Authors:  J E Leon; B Bissonnette
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

7.  Mechanisms of inhibition of endothelium-dependent relaxation by halothane, isoflurane, and sevoflurane.

Authors:  K Nakamura; K Terasako; H Toda; I Miyawaki; M Kakuyama; M Nishiwada; Y Hatano; K Mori
Journal:  Can J Anaesth       Date:  1994-04       Impact factor: 5.063

8.  Vascular aging and hemodynamic stability in the intraoperative period.

Authors:  Ferrante S Gragasin; Stephane L Bourque; Sandra T Davidge
Journal:  Front Physiol       Date:  2012-04-02       Impact factor: 4.566

Review 9.  Time to wake up: Studying neurovascular coupling and brain-wide circuit function in the un-anesthetized animal.

Authors:  Yu-Rong Gao; Yuncong Ma; Qingguang Zhang; Aaron T Winder; Zhifeng Liang; Lilith Antinori; Patrick J Drew; Nanyin Zhang
Journal:  Neuroimage       Date:  2016-11-28       Impact factor: 6.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.